comparemela.com

Latest Breaking News On - Ted love - Page 4 : comparemela.com

Global Blood Therapeutics (GBT) Q1 2022 Earnings Call Transcript

GBT earnings call for the period ending March 31, 2022.

United statesUnited kingdomGreat britainKim smith whitleySteven immergutDavid johnsonJeff farrowAlan andersonOxbryta expanded access programSteven immergut head of communicationsEuropean commissionEuropean hematology associationAmerican society of pediatric hematology oncologySource solutionsGlobal blood therapeuticsTed love

Dr Ted Love speaks at NBCI s State of the State of Sickle Cell Disease event

The NBCI event featured a session by Ted W. Love, M.D., president and CEO of Global Blood Therapeutics (GBT).

Bishop adejubeBusiness development at sickle cell foundationTed loveBronaugh bridgesBusiness developmentSickle cell foundation

CEO Dr Ted Love removed pain and suffering from sickle cell patients with Oxbryta®

Dr. Ted Love came out of retirement to fight for the Black community against SCD and is encouraging Black children to study medicine.

United statesGlobal blood therapeutics incGlobal blood therapeuticsTed loveJim crow southMiddle east

Global Blood Therapeutics (GBT) Q4 2021 Earnings Call Transcript

GBT earnings call for the period ending December 31, 2021.

United statesFrance generalUnited kingdomCity ofDavid johnsonRaju prasad william blairRaymond jamesJason gerberryKim smith whitleyJoon lee truistSteven immergutAlethia youngAlethia young cantor fitzgeraldDanielle brill raymond jamesJoon leeAmerica merrill lynch

Health IQ Live Broadcast with Dr Ted Love discussing Sickle Cell Anemia

Health IQ "Live" Broadcast with Dr. Ted Love discussing Sickle Cell Anemia

Rolling out healthTed loveRolling outSickle cell anemia

vimarsana © 2020. All Rights Reserved.